ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
Nov 09, 2007
Elite Pharmaceuticals, Inc. Concludes a Special Protocol Assessment with the FDA on a Pivotal Phase 3 Study on Elite's Abuse Deterrent Oxycodone Product
Nov 01, 2007
Elite Pharmaceuticals to Present at Acumen BioFin 9th Annual Healthcare Conference
Jul 17, 2007
ELITE ANNOUNCES CLOSING OF SERIES C PRIVATE PLACEMENT
Jun 28, 2007
Elite Pharmaceuticals Provides Update on Company's Progress and Projected Milestones
Jun 26, 2007
ROBERT J. LEVENSON ELECTED TO THE BOARD OF DIRECTORS OF ELITE PHARMACEUTICALS, INC.
Jun 05, 2007
ELITE PHARMACEUTICALS TO PRESENT AT FTN MIDWEST SECRUITIES 2007 HEALTHCARE CONFERENCE
May 10, 2007
ELITE PHARMACEUTICALS TO PRESENT AT RODMAN & RENSHAW 4th ANNUAL GLOBAL HEALTHCARE CONFERENCE
Apr 24, 2007
ELITE ANNOUNCES CLOSING OF $15,000,000 PRIVATE PLACEMENT
Feb 28, 2007
Elite to Present at the Oppenheimer "Positioning Investors for the Next Wave in Pain Management" Conference in New York City on March 6, 2007
Feb 15, 2007
Elite Pharmaceuticals Provides Positive Clinical Update
16
17
18
19
20
21
22
23
24
25
26
<<
<
>
>>
Back to top
Privacy
